Human infections with highly pathogenic avian influenza A(H5N1) viruses in the United States from March 2024 to May 2025

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Nature Medicine

• Publication date

  2025-07-25

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1038/s41591-025-03905-2PMID 40712649PMCID PMC12477757
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influenza A(H5N1) Immune Response among Ferrets with Influenza A(H1N1)pdm09 Immunity

  2025cited by this paper
• Highly pathogenic avian influenza H5N1: history, current situation, and outlook

  2025cited by this paper
• Immune history shapes human antibody responses to H5N1 influenza viruses

  2025cited by this paper
• Neutralizing Antibody Response to Influenza A(H5N1) Virus in Dairy Farm Workers, Michigan, USA

  2025cited by this paper
• Effect of Prior Influenza A(H1N1)pdm09 Virus Infection on Pathogenesis and Transmission of Human Influenza A(H5N1) Clade 2.3.4.4b Virus in Ferret Model

  2025cited by this paper
• Exposure Practices to Animal‐Origin Influenza A Virus at the Animal–Human Interface in Poultry and Swine Backyard Farms

  2024cited by this paper
• An Update on Highly Pathogenic Avian Influenza A(H5N1) Virus, Clade 2.3.4.4b.

  2024cited by this paper
• Emergence and interstate spread of highly pathogenic avian influenza A(H5N1) in dairy cattle

  2024cited by this paper
• Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker.

  2024cited by this paper
• The impact of PA/I38 substitutions and PA polymorphisms on the susceptibility of zoonotic influenza A viruses to baloxavir

  2024cited by this paper
• Highly pathogenic avian influenza A(H5N1) virus in a common bottlenose dolphin (Tursiops truncatus) in Florida

  2024cited by this paper
• Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans.

  2024cited by this paper
• Critical Illness in an Adolescent with Influenza A(H5N1) Virus Infection.

  2024cited by this paper
• Genotypic Clustering of H5N1 Avian Influenza Viruses in North America Evaluated by Ordination Analysis

  2024cited by this paper
• A human isolate of bovine H5N1 is transmissible and lethal in animal models

  2024cited by this paper
• Risk for Infection in Humans after Exposure to Birds Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus, United States, 2022

  2023cited by this paper
• Interpretation of molecular detection of avian influenza A virus in respiratory specimens collected from live bird market workers in Dhaka, Bangladesh: infection or contamination?

  2023cited by this paper
• H5N1 highly pathogenic avian influenza clade 2.3.4.4b in wild and domestic birds: Introductions into the United States and reassortments, December 2021-April 2022.

  2023cited by this paper
• Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022

  2023cited by this paper
• Reported Global Avian Influenza Detections Among Humans and Animals During 2013-2022: Comprehensive Review and Analysis of Available Surveillance Data

  2023cited by this paper
• First case of human infection with highly pathogenic H5 avian Influenza A virus in South America: A new zoonotic pandemic threat for 2023?

  2023cited by this paper
• Transatlantic spread of highly pathogenic avian influenza H5N1 by wild birds from Europe to North America in 2021

  2022cited by this paper
• Assessment of poultry rearing practices and risk factors of H5N1 and H9N2 virus circulating among backyard chickens and ducks in rural communities

  2022cited by this paper
• Intercontinental Movement of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4 Virus to the United States, 2021

  2022cited by this paper
• Factors influencing chicken farmers' decisions to implement prevention and control measures to reduce avian influenza virus spread under endemic conditions.

  2020cited by this paper
• Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost

  2019cited by this paper
• Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans

  2017cited by this paper
• Viral deep sequencing needs an adaptive approach: IRMA, the iterative refinement meta-assembler

  2016cited by this paper
• Understanding the failure of a behavior change intervention to reduce risk behaviors for avian influenza transmission among backyard poultry raisers in rural Bangladesh: a focused ethnography

  2016cited by this paper
• Locating rearrangement events in a phylogeny based on highly fragmented assemblies

  2016cited by this paper
• Household practices related to disease transmission between animals and humans in rural Cambodia

  2015cited by this paper
• Adamantane-Resistant Influenza A Viruses in the World (1902–2013): Frequency and Distribution of M2 Gene Mutations

  2015cited by this paper
• PB2 Mutations D701N and S714R Promote Adaptation of an Influenza H5N1 Virus to a Mammalian Host

  2014cited by this paper
• Mammalian Adaptation in the PB2 Gene of Avian H5N1 Influenza Virus

  2013cited by this paper
• Bangladeshi backyard poultry raisers' perceptions and practices related to zoonotic transmission of avian influenza.

  2012cited by this paper
• Use of Personal Protective Measures by Thai Households in Areas with Avian Influenza Outbreaks

  2012cited by this paper
• Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses.

  2011cited by this paper
• Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation.

  2011cited by this paper
• Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009.

  2010cited by this paper
• Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic.

  2010cited by this paper
• Single-Reaction Genomic Amplification Accelerates Sequencing and Vaccine Production for Classical and Swine Origin Human Influenza A Viruses

  2009cited by this paper
• Transmission of Influenza Virus in a Mammalian Host Is Increased by PB2 Amino Acids 627K or 627E/701N

  2009cited by this paper
• Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air

  2009cited by this paper
• Selection of H5N1 Influenza Virus PB2 during Replication in Humans

  2009cited by this paper
• Sialic acid tissue distribution and influenza virus tropism

  2008cited by this paper
• An Avian Influenza H5N1 Virus That Binds to a Human-Type Receptor

  2007cited by this paper
• H5N1 Virus Attachment to Lower Respiratory Tract

  2006cited by this paper
• Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors

  2006cited by this paper
• Avian flu: Influenza virus receptors in the human airway

  2006cited by this paper
• Poultry-handling Practices during Avian Influenza Outbreak, Thailand

  2005cited by this paper
• Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts.

  1999cited by this paper

• Avian Influenza Viruses: Global Panzootic, Host Range Expansion and Emerging One-Health Threats

  2026cites this paper
• From pandemic influenza to novel coronaviruses: emerging infectious diseases of the 21st century.

  2026cites this paper
• Management of critical illness in an adolescent caused by highly pathogenic avian influenza A(H5N1) virus infection in British Columbia, Canada.

  2026cites this paper
• Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice.

  2026cites this paper
• Primary bovine embryonic fibroblasts demonstrate variable fitness following infection with highly pathogenic avian influenza H5N1 strains and are susceptible to a recently circulating human 2009 pandemic lineage H1N1 strain

  2026cites this paper
• A pandemic toolbox for clade 2.3.4.4b A(H5N1) influenza virus risk assessment.

  2025cites this paper
• Risk of infection of dairy cattle in the EU with highly pathogenic avian influenza virus affecting dairy cows in the United States of America (H5N1, Eurasian lineage goose/Guangdong clade 2.3.4.4b. genotype B3.13)

  2025cites this paper
• Understanding avian influenza mortality.

  2025cites this paper
• Converging Influenza Threats: Seasonal A(H3N2) (including subclade K) Dynamics and the Persistent Pandemic Risk of A(H5N1).

  2025cites this paper
• Expanding Horizons: Host Range Evolution and Treatment Strategies for Highly Pathogenic Avian Influenza H5N1 and H7N9

  2025cites this paper
• Influenza A Virus H5N1 Subtype: Resurgent Interspecies and Intercontinental Transmission, and a New Host

  2025influential citation
• Avian influenza overview June–September 2025

  2025cites this paper
• Better models mean better risk assessment for influenza A infection

  2025cites this paper
• Transmission, Pathological and Clinical Manifestations of Highly Pathogenic Avian Influenza A Virus in Mammals with Emphasis on H5N1 Clade 2.3.4.4b

  2025cites this paper
• Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses from humans in the United States, October 2024 to February 2025

  2025influential citation